Related Experiment Video
Updated: Aug 12, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Heterogeneity in the phosphorylation of human death receptors by p42(mapk/erk2)
S K Frankel1, A A Van Linden, D W Riches
1Program in Cell Biology, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA.
Abstract:
Phosphorylation of murine CD120a by p42(mapk/erk2) has been shown to inhibit its ability to initiate apoptosis while preserving signaling events such as NF-kappaB activation. Therefore, we sought to determine if p42(mapk/erk2) was also capable of phosphorylating additional human death receptors within the TNF receptor superfamily. These studies showed that CD120a and DR3 are significantly phosphorylated by p42(mapk/erk2) but Fas, DR4 and DR5 are not. Additionally, we demonstrated that (i) the p42(mapk/erk2)-dependent phosphorylation of CD120a and DR3 occurred on Ser and Thr residues, (ii) p42(mapk/erk2) phosphorylated residues located in the membrane proximal regions but not the death domains of CD120a and DR3, (iii) Ser 253 is a preferred site of phosphorylation on CD120a, and (iv) the p42(mapk/erk2)-dependent phosphorylation of the DR3 cytoplasmic domain occurred exclusively at non-p42/44(mapk/erk2/1) consensus sites. These findings suggest that human death receptors segregate into two groups along lines of phylogeny with respect to Ser/Thr phosphorylation by p42(mapk/erk2).
Insights
p42(MAPK/ERK2) phosphorylates human CD120a and DR3 death receptors, affecting apoptosis signaling. This phosphorylation occurs on specific residues, differentiating receptors based on their response to this kinase.
Area of Science:
- Molecular Biology
- Cell Signaling
- Immunology
Background:
- p42(MAPK/ERK2) phosphorylation of murine CD120a inhibits apoptosis initiation.
- This phosphorylation preserves signaling pathways like NF-kappaB activation.
Purpose of the Study:
- To investigate if p42(MAPK/ERK2) phosphorylates other human death receptors in the TNF receptor superfamily.
- To identify which human death receptors are substrates for p42(MAPK/ERK2).
Main Methods:
- Western blotting and phospho-specific antibodies to detect phosphorylation.
- Site-directed mutagenesis to identify phosphorylation sites.
- Analysis of TNF receptor superfamily members including CD120a, DR3, Fas, DR4, and DR5.
Main Results:
- CD120a and DR3 were significantly phosphorylated by p42(MAPK/ERK2).
- Fas, DR4, and DR5 were not phosphorylated by p42(MAPK/ERK2).
- Phosphorylation occurred on Ser/Thr residues in membrane-proximal regions, not death domains, with Ser 253 being a key site on CD120a.
Conclusions:
- Human death receptors can be categorized based on their susceptibility to p42(MAPK/ERK2)-mediated Ser/Thr phosphorylation.
- p42(MAPK/ERK2) plays a role in regulating apoptosis signaling through differential phosphorylation of death receptors.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway

